These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 21997545)

  • 1. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis.
    Hassan C; Rex DK; Cooper GS; Zullo A; Launois R; Benamouzig R
    Gut; 2012 Aug; 61(8):1172-9. PubMed ID: 21997545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination aspirin and/or calcium chemoprevention with colonoscopy in colorectal cancer prevention: cost-effectiveness analyses.
    Pence BC; Belasco EJ; Lyford CP
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):399-405. PubMed ID: 23250933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
    Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists.
    Hassan C; Rex DK; Zullo A; Cooper GS
    Cancer; 2012 Sep; 118(18):4404-11. PubMed ID: 22707430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN; Ladabaum U
    Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.
    Hassan C; Zullo A; Winn S; Morini S
    Endoscopy; 2008 May; 40(5):414-21. PubMed ID: 18302080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy.
    Hassan C; Zullo A; Laghi A; Reitano I; Taggi F; Cerro P; Iafrate F; Giustini M; Winn S; Morini S
    Dig Liver Dis; 2007 Mar; 39(3):242-50. PubMed ID: 17112797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening based on risk for colorectal cancer is the most cost-effective approach.
    Dan YY; Chuah BY; Koh DC; Yeoh KG
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):266-71.e1-6. PubMed ID: 22100624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis.
    DuPont AW; Arguedas MR; Wilcox CM
    Aliment Pharmacol Ther; 2007 Aug; 26(3):431-41. PubMed ID: 17635378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals.
    Hur C; Simon LS; Gazelle GS
    Cancer; 2004 Jul; 101(1):189-97. PubMed ID: 15222006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summaries for patients. Is aspirin a cost-effective addition to colorectal cancer screening?
    Ann Intern Med; 2001 Nov; 135(9):1. PubMed ID: 11759636
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.
    Lucidarme O; Cadi M; Berger G; Taieb J; Poynard T; Grenier P; Beresniak A
    Eur J Radiol; 2012 Jul; 81(7):1413-9. PubMed ID: 21444171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopist-directed propofol administration versus anesthesiologist assistance for colorectal cancer screening: a cost-effectiveness analysis.
    Hassan C; Rex DK; Cooper GS; Benamouzig R
    Endoscopy; 2012 May; 44(5):456-64. PubMed ID: 22531982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is virtual colonoscopy a cost-effective option to screen for colorectal cancer?
    Sonnenberg A; Delcò F; Bauerfeind P
    Am J Gastroenterol; 1999 Aug; 94(8):2268-74. PubMed ID: 10445561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of colorectal cancer.
    Winawer SJ
    Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries.
    Wu GH; Wang YM; Yen AM; Wong JM; Lai HC; Warwick J; Chen TH
    BMC Cancer; 2006 May; 6():136. PubMed ID: 16723013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk analyses for screening sigmoidoscopy based on a colorectal cancer (CRC) population.
    Mulder SA; Ouwendijk RJ; Giard RW; Van Leerdam ME; Kuipers EJ
    Scand J Gastroenterol; 2009; 44(2):205-10. PubMed ID: 18836946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.